作者：
Sungwoo,Park [1]
;
Jae-Cheol,Jo [2]
;
Young Rok,Do [3]
;
Deok-Hwan,Yang [4]
;
Sung-Nam,Lim [5]
;
Won-Sik,Lee [6]
;
Won Seog,Kim [7]
;
Ho Sup,Lee [8]
;
Dae-Sik,Hong [9]
;
Hyo Jung,Kim [10]
;
Ho-Jin,Shin [11]
作者单位：
Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea; Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Republic of Korea.
[1]
Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
[2]
Division of Hematology-Oncology, Keimyung University, School of Medicine, Keimyung University Hospital, Daegu, Republic of Korea.
[3]
Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, Republic of Korea.
[4]
Department of internal medicine, Inje university college of medicine, Haeundae Paik hospital, Busan, Republic of Korea.
[5]
Department of Internal Medicine, Division of Hemato-Oncology, Inje University Busan Paik Hospital, Busan, Republic of Korea.
[6]
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
[7]
Division of Hematology-Oncology, Kosin University Gospel Hospital, Busan, South Korea.
[8]
Department of Internal Medicine, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.
[9]
Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea.
[10]
Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea. Electronic address: hojinja@hanmail.net.
[11]
DOI
10.1016/j.clml.2018.11.003
PMID
30581162
发布时间
2020-06-03
换一批
换一批
